Tvardi Therapeutics Stock Price, News & Analysis
TVRD
NASDAQ
Company Description
Welcome to the overview page for Tvardi Therapeutics (TVRD), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$24.00
0.00%
0.00
Last updated: August 17, 2025 at 16:00
59.41 %
Performance 1 year
$222.2M
Market Cap
9.4M
Shares outstanding
Latest News
SEC Filings
Financial Highlights
$0
Revenue (TTM)
$4,167,000
Net Income (TTM)
-$1.00
Diluted EPS (TTM)
-$8,865,000
Operating Cash Flow
4.04
Current Ratio
-$8,869,000
Operating Income
Upcoming Events
October 1, 2025 - December 31, 2025
Phase 2 data release
Expected topline data from REVERT IPF Phase 2 trial
October 1, 2025 - December 31, 2025
Phase 2 topline data
Topline results expected for REVERT IPF Phase 2 trial of TTI-101
January 1, 2026
Liver cancer trial preliminary data
Frequently Asked Questions
What is the current stock price of Tvardi Therapeutics (TVRD)?
The current stock price of Tvardi Therapeutics (TVRD) is $24 as of August 15, 2025.
What is the market cap of Tvardi Therapeutics (TVRD)?
The market cap of Tvardi Therapeutics (TVRD) is approximately 222.2M.
What is the revenue (TTM) of Tvardi Therapeutics (TVRD) stock?
The trailing twelve months (TTM) revenue of Tvardi Therapeutics (TVRD) is $0.
What is the net income of Tvardi Therapeutics (TVRD)?
The trailing twelve months (TTM) net income of Tvardi Therapeutics (TVRD) is $4,167,000.
What is the earnings per share (EPS) of Tvardi Therapeutics (TVRD)?
The diluted earnings per share (EPS) of Tvardi Therapeutics (TVRD) is -$1.00 on a trailing twelve months (TTM) basis.
What is the operating cash flow of Tvardi Therapeutics (TVRD)?
The operating cash flow of Tvardi Therapeutics (TVRD) is -$8,865,000.
What is the current ratio of Tvardi Therapeutics (TVRD)?
The current ratio of Tvardi Therapeutics (TVRD) is 4.04, indicating the company's ability to pay short-term obligations.
What is the operating income of Tvardi Therapeutics (TVRD)?
The operating income of Tvardi Therapeutics (TVRD) is -$8,869,000.